Law360, New York (July 19, 2012, 9:32 PM ET) -- A New York federal judge refused Wednesday to drop China Pharmaceutical Group Ltd. from multidistrict price-fixing litigation against several Chinese vitamin C producers, ruling that the company had enough control over its manufacturing subsidiary to remain in the case.
U.S. District Judge Brian M. Cogan denied a pair of long-outstanding motions from China Pharmaceutical to exit the case, based on the company's claims that the court lacked jurisdiction over it and that the plaintiffs couldn't prove it had attended any price-fixing meetings on its own behalf....
Judge Won't Cut Weisheng Parent From Vitamin C Cartel Case
To view the full article, take a free trial now.
